118 related articles for article (PubMed ID: 34666104)
1. Evaluation of the angiogenic properties of Brugia malayi asparaginyl-tRNA synthetase and its mutants: A study on the molecular target for antifilarial drug development.
Chandrasekar R; Sivanesan S; Natarajan M; Naveena K; Preetha N; Karthika S; Vimalraj S; Kron M; Dhanasekaran A
Mol Biochem Parasitol; 2021 Nov; 246():111426. PubMed ID: 34666104
[TBL] [Abstract][Full Text] [Related]
2. Brugia malayi Asparaginyl-tRNA Synthetase Stimulates Endothelial Cell Proliferation, Vasodilation and Angiogenesis.
D JJ; Dhanraj M; Solaiappan S; Sivanesan S; Kron M; Dhanasekaran A
PLoS One; 2016; 11(1):e0146132. PubMed ID: 26751209
[TBL] [Abstract][Full Text] [Related]
3. Immune Response to
Hameed A; Natarajan M; Jabbar S; Dhanasekaran JJ; Kumar K; Sivanesan S; Kron M; Dhanasekaran A
Lymphat Res Biol; 2019 Aug; 17(4):447-456. PubMed ID: 30570354
[No Abstract] [Full Text] [Related]
4. New WS9326A congeners from Streptomyces sp. 9078 inhibiting Brugia malayi asparaginyl-tRNA synthetase.
Yu Z; Vodanovic-Jankovic S; Kron M; Shen B
Org Lett; 2012 Sep; 14(18):4946-9. PubMed ID: 22967068
[TBL] [Abstract][Full Text] [Related]
5. Expression, localization and alternative function of cytoplasmic asparaginyl-tRNA synthetase in Brugia malayi.
Kron M; Petridis M; Milev Y; Leykam J; Härtlein M
Mol Biochem Parasitol; 2003 Jun; 129(1):33-9. PubMed ID: 12798504
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoinformatics-based screening of active compounds from Vitex negundo against lymphatic filariasis by targeting asparaginyl-tRNA synthetase.
Kabilan SJ; Kunjiappan S; Sundar K; Pavadai P; Sathishkumar N; Velayuthaperumal H
J Mol Model; 2023 Mar; 29(4):87. PubMed ID: 36872402
[TBL] [Abstract][Full Text] [Related]
7. Virtual screening of traditional Chinese medicine (TCM) database: identification of fragment-like lead molecules for filariasis target asparaginyl-tRNA synthetase.
Arya H; Coumar MS
J Mol Model; 2014 Jun; 20(6):2266. PubMed ID: 24842326
[TBL] [Abstract][Full Text] [Related]
8. An immunodominant antigen of Brugia malayi is an asparaginyl-tRNA synthetase.
Kron M; Marquard K; Härtlein M; Price S; Leberman R
FEBS Lett; 1995 Oct; 374(1):122-4. PubMed ID: 7589498
[TBL] [Abstract][Full Text] [Related]
9. Brugia malayi asparaginyl-transfer RNA synthetase induces chemotaxis of human leukocytes and activates G-protein-coupled receptors CXCR1 and CXCR2.
Ramirez BL; Howard OM; Dong HF; Edamatsu T; Gao P; Hartlein M; Kron M
J Infect Dis; 2006 Apr; 193(8):1164-71. PubMed ID: 16544258
[TBL] [Abstract][Full Text] [Related]
10. Asparaginyl-tRNA synthetase pre-transfer editing assay.
Danel F; Caspers P; Nuoffer C; Härtlein M; Kron MA; Page MG
Curr Drug Discov Technol; 2011 Mar; 8(1):66-75. PubMed ID: 21091430
[TBL] [Abstract][Full Text] [Related]
11. Tirandamycins from Streptomyces sp. 17944 inhibiting the parasite Brugia malayi asparagine tRNA synthetase.
Yu Z; Vodanovic-Jankovic S; Ledeboer N; Huang SX; Rajski SR; Kron M; Shen B
Org Lett; 2011 Apr; 13(8):2034-7. PubMed ID: 21405052
[TBL] [Abstract][Full Text] [Related]
12. A hybrid structural model of the complete Brugia malayi cytoplasmic asparaginyl-tRNA synthetase.
Crepin T; Peterson F; Haertlein M; Jensen D; Wang C; Cusack S; Kron M
J Mol Biol; 2011 Jan; 405(4):1056-69. PubMed ID: 21134380
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-8-like activity in a filarial asparaginyl-tRNA synthetase.
Kron MA; Wang C; Vodanovic-Jankovic S; Howard OM; Kuhn LA
Mol Biochem Parasitol; 2012 Sep; 185(1):66-9. PubMed ID: 22710390
[TBL] [Abstract][Full Text] [Related]
14. Adipostatins A-D from Streptomyces sp. 4875 inhibiting Brugia malayi asparaginyl-tRNA synthetase and killing adult Brugia malayi parasites.
Rateb ME; Yang D; Vodanovic-Jankovic S; Yu Z; Kron MA; Shen B
J Antibiot (Tokyo); 2015 Aug; 68(8):540-2. PubMed ID: 25735843
[No Abstract] [Full Text] [Related]
15. Nematode asparaginyl-tRNA synthetase resolves intestinal inflammation in mice with T-cell transfer colitis.
Kron MA; Metwali A; Vodanovic-Jankovic S; Elliott D
Clin Vaccine Immunol; 2013 Feb; 20(2):276-81. PubMed ID: 23254300
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Brugia malayi antigenic peptides: candidates for synthetic vaccine design against lymphatic filariasis.
Gomase VS; Chitlange NR; Changbhale SS; Kale KV
Protein Pept Lett; 2013 Aug; 20(8):864-87. PubMed ID: 23537185
[TBL] [Abstract][Full Text] [Related]
17. Computational screening of potential inhibitors targeting MurF of Brugia malayi Wolbachia through multi-scale molecular docking, molecular dynamics and MM-GBSA analysis.
Poopandi S; Sundaraj R; Rajmichael R; Thangaraj S; Dhamodharan P; Biswal J; Malaisamy V; Jeyaraj Pandian C; Jeyaraman J
Mol Biochem Parasitol; 2021 Nov; 246():111427. PubMed ID: 34666103
[TBL] [Abstract][Full Text] [Related]
18. In Vitro and In Vivo Antifilarial Activity of Standardized Extract of Calotropis procera Flowers against Brugia malayi.
Kushwaha V; Rastogi S; Pandey MM; Saxena K; Khatoon S; Rawat AKS; Murthy PK
Curr Top Med Chem; 2019; 19(14):1252-1262. PubMed ID: 31218959
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning, purification and characterisation of myosin of human lymphatic filarial parasite Brugia malayi.
Verma SK; Bansal I; Vedi S; Saxena JK; Katoch VM; Bhattacharya SM
Parasitol Res; 2008 Feb; 102(3):481-9. PubMed ID: 18064491
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic impact on Brugia malayi by sulphonamido-quinoxaline: search for a novel therapeutic rationale.
Bhoj PS; Ingle RG; Goswami K; Jena L; Wadher S
Parasitol Res; 2018 May; 117(5):1559-1572. PubMed ID: 29568978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
